These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 17953961)

  • 1. Economic cost for implementation of the U.S. Food and Drug Administration's Code of Federal Regulations Title 21, Part 1271 in an egg donor program.
    Baker VL; Gvakharia MO; Rone HM; Manalad JR; Adamson GD
    Fertil Steril; 2008 Sep; 90(3):537-45. PubMed ID: 17953961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic evaluation of oocyte donors: recipient couple preferences and outcome of testing.
    Baker VL; Rone HM; Adamson GD
    Fertil Steril; 2008 Dec; 90(6):2091-8. PubMed ID: 18249390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
    Inadomi JM
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using the exception from informed consent regulations in research.
    Mosesso VN; Cone DC
    Acad Emerg Med; 2005 Nov; 12(11):1031-9. PubMed ID: 16264070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic evaluation of public-private mix for tuberculosis care and control, India. Part II. Cost and cost-effectiveness.
    Pantoja A; Lönnroth K; Lal SS; Chauhan LS; Uplekar M; Padma MR; Unnikrishnan KP; Rajesh J; Kumar P; Sahu S; Wares F; Floyd K
    Int J Tuberc Lung Dis; 2009 Jun; 13(6):705-12. PubMed ID: 19460245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluation of public-private mix for tuberculosis care and control, India. Part I. Socio-economic profile and costs among tuberculosis patients.
    Pantoja A; Floyd K; Unnikrishnan KP; Jitendra R; Padma MR; Lal SS; Uplekar M; Chauhan LS; Kumar P; Sahu S; Wares F; Lönnroth K
    Int J Tuberc Lung Dis; 2009 Jun; 13(6):698-704. PubMed ID: 19460244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Medico-economic assessment of two methods for implementing thyroid testing guidelines].
    Saillour-Glénisson F; Michel P; Daucourt V
    Rev Epidemiol Sante Publique; 2005 Sep; 53 Spec No 1():1S79-88. PubMed ID: 16327743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [S3 Guideline on "sedation in gastrointestinal endoscopy": how much does the new guideline cost in everyday hospital work? A calculation model and analysis of implementation in 2011 among ALGK members].
    Behrens A; Kainzinger FA; Nölling T; Wienke A; Pech O; Ell C
    Z Gastroenterol; 2012 Sep; 50(9):1002-7. PubMed ID: 22965630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 21 CFR (Code of Federal Regulations) online database: Food and Drug Administration regulations full-text.
    Bobka MS
    Med Ref Serv Q; 1993; 12(1):7-15. PubMed ID: 10126251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MAC regulations: their predicted economic impact on pharmaceutical reimbursement.
    Gammill CG; Francis WR
    Contemp Pharm Pract; 1981; 4(1):32-6. PubMed ID: 10298086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why implementation processes vary across the 5A's of the Smoking Cessation Guideline: administrators' perspectives.
    Manfredi C; LeHew CW
    Nicotine Tob Res; 2008 Nov; 10(11):1597-607. PubMed ID: 18988072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost-effectiveness of implementing a new guideline for cardiovascular risk management in primary care in the Netherlands.
    Kok L; Engelfriet P; Jacobs-van der Bruggen MA; Hoogenveen RT; Boshuizen HC; Verschuren MW
    Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):371-6. PubMed ID: 19305351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical trial primer: historical perspective and modern implementation.
    Karsh LI
    Urol Oncol; 2012; 30(4 Suppl):S28-32. PubMed ID: 22795078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physician refer thyself: is Stark II, phase III the final voyage?
    Manchikanti L; McMahon EB
    Pain Physician; 2007 Nov; 10(6):725-41. PubMed ID: 17987094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and economic impact of a clinical pathway for pap test utilization in Gynecologic Oncology practice.
    Santillan A; Govan L; Zahurak ML; Diaz-Montes TP; Giuntoli RL; Bristow RE
    Gynecol Oncol; 2008 Jun; 109(3):388-93. PubMed ID: 18405946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eligibility determination for donors of human cells, tissues, and cellular and tissue-based products. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 May; 69(101):29785-834. PubMed ID: 15160713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a training program for device operators in the Australian Government's Point of Care Testing in General Practice Trial: issues and implications for rural and remote practices.
    Shephard MD; Mazzachi BC; Watkinson L; Shephard AK; Laurence C; Gialamas A; Bubner T
    Rural Remote Health; 2009; 9(3):1189. PubMed ID: 19689171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.